Trials / Completed
CompletedNCT03592628
Enhancing Postpartum Discharge Instructions
Enhancing Postpartum Discharge Instructions for Cesarean Incision Care With Assessment of Comprehension: A Pilot Randomized Controlled Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 50 (actual)
- Sponsor
- Thomas Jefferson University · Academic / Other
- Sex
- Female
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
Post-cesarean delivery discharge instructions are not currently at an appropriate health literacy level. Enhancing discharge instructions with a visual aid did not improve scores on comprehension quizzes, either immediately or two-weeks post-discharge. However, participants preferred to have access to visual images with discharge instructions.
Detailed description
Objective: To evaluate the effect of a visual aid on improving comprehension of hospital discharge instructions for cesarean wound care. Methods: A randomized control trial with a 1:1 allocation ratio and an intention to treat analysis was performed at an urban, tertiary care center from June-November 2017. Fifty English-speaking patients ages 18-50 who had undergone a cesarean delivery were randomized to receive either standard or enhanced discharge instructions regarding post-cesarean incision care. Enhanced instructions included a visual aid not present in the standard instructions. Participants completed a comprehension quiz prior to hospital discharge and again 2 weeks after discharge as well as the REALM literacy assessment prior to discharge.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Visual Aid | The visual aid was a one-sheet diagram with illustrations of important features of post-cesarean wound care. |
| OTHER | Standard Instructions | Standard discharge instructions WITHOUT supplement of visual aid. |
Timeline
- Start date
- 2017-06-01
- Primary completion
- 2017-11-30
- Completion
- 2018-07-03
- First posted
- 2018-07-19
- Last updated
- 2018-07-19
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03592628. Inclusion in this directory is not an endorsement.